Healthcare provider profile · identity verified

John C Earle, M.D.

Family Practice · CARROLLTON, GA · NPI 1376625087

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	338	47
Amlodipine Besylate	Amlodipine Besylate	273	69
Levothyroxine Sodium	Levothyroxine Sodium	244	59
Gabapentin	Gabapentin	211	48
Pantoprazole Sodium	Pantoprazole Sodium	196	51
Alprazolam	Alprazolam	184	29
Pravastatin Sodium	Pravastatin Sodium	177	38
Losartan Potassium	Losartan Potassium	163	46
Metformin Hcl	Metformin Hcl	163	45
Atorvastatin Calcium	Atorvastatin Calcium	162	45
Metoprolol Succinate	Metoprolol Succinate	156	39
Albuterol Sulfate Hfa	Albuterol Sulfate	150	40
Prednisone	Prednisone	150	59
Furosemide	Furosemide	148	39
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	147	15
Glimepiride	Glimepiride	140	33
Omeprazole	Omeprazole	135	35
Lisinopril	Lisinopril	126	33
Azithromycin	Azithromycin	118	69
Hydrochlorothiazide	Hydrochlorothiazide	116	41
Allopurinol	Allopurinol	114	26
Zolpidem Tartrate	Zolpidem Tartrate	113	19
Simvastatin	Simvastatin	112	28
Jardiance	Empagliflozin	108	21
Potassium Chloride	Potassium Chloride	101	28
Diclofenac Sodium	Diclofenac Sodium	96	21
Ozempic	Semaglutide	95	12
Tamsulosin Hcl	Tamsulosin Hcl	81	24
Meloxicam	Meloxicam	80	22
Fluticasone Propionate	Fluticasone Propionate	79	16
Amoxicillin	Amoxicillin	75	43
Tramadol Hcl	Tramadol Hcl	72	18
Carvedilol	Carvedilol	69	21
Clonazepam	Clonazepam	69	12
Donepezil Hcl	Donepezil Hcl	67	16
Montelukast Sodium	Montelukast Sodium	66	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	17
Rosuvastatin Calcium	Rosuvastatin Calcium	63	15
Quetiapine Fumarate	Quetiapine Fumarate	61	11
Clopidogrel	Clopidogrel Bisulfate	60	17
Alendronate Sodium	Alendronate Sodium	56	18
Terazosin Hcl	Terazosin Hcl	56	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Metformin Hcl Er	Metformin Hcl	50	13
Tizanidine Hcl	Tizanidine Hcl	50	11
Ibuprofen	Ibuprofen	49	17
Lorazepam	Lorazepam	47	suppressed
Atenolol	Atenolol	46	suppressed
Januvia	Sitagliptin Phosphate	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	44	14
Duloxetine Hcl	Duloxetine Hcl	43	12
Eliquis	Apixaban	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	42	13
Amitriptyline Hcl	Amitriptyline Hcl	40	12
Glipizide Er	Glipizide	40	12
Pregabalin	Pregabalin	40	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	21
Meclizine Hcl	Meclizine Hcl	39	13
Trazodone Hcl	Trazodone Hcl	39	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	27
Finasteride	Finasteride	38	13
Famotidine	Famotidine	37	17
Myrbetriq	Mirabegron	37	suppressed
Celecoxib	Celecoxib	35	suppressed
Diazepam	Diazepam	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	35	suppressed
Testosterone Cypionate	Testosterone Cypionate	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	32	suppressed
Estradiol	Estradiol	32	suppressed
Fluconazole	Fluconazole	31	14
Memantine Hcl	Memantine Hcl	31	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	11
Temazepam	Temazepam	31	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Mounjaro	Tirzepatide	26	suppressed
Ondansetron Odt	Ondansetron	26	14
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	16
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Cephalexin	Cephalexin	23	12
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Ramipril	Ramipril	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Indapamide	Indapamide	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	20	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glipizide	Glipizide	19	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	18	suppressed
Hydrocortisone	Hydrocortisone	18	12
Baclofen	Baclofen	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Cefdinir	Cefdinir	16	12
Fenofibrate	Fenofibrate	16	suppressed
Invokana	Canagliflozin	16	suppressed
Novolin N	Insulin Nph Human Isophane	16	suppressed
Primidone	Primidone	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Armour Thyroid	Thyroid,pork	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Linzess	Linaclotide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Naproxen	Naproxen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Clozapine	Clozapine	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Xyosted	Testosterone Enanthate	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Lubiprostone	Lubiprostone	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxaprozin	Oxaprozin	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error